289
Views
27
CrossRef citations to date
0
Altmetric
Helicobacter pylori

A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea

, , , , , , & show all
Pages 917-924 | Received 12 Jan 2014, Accepted 13 Feb 2014, Published online: 03 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yong Hwan Kwon, Nayoung Kim, Ju Yup Lee, Yoon Jin Choi, Kichul Yoon, Ryung Hee Nam, Ji Hyung Suh, Jung Won Lee & Dong Ho Lee. (2016) Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study. Scandinavian Journal of Gastroenterology 51:3, pages 270-276.
Read now

Articles from other publishers (26)

Jian‐Wei Yun, Cui Wang, Yi Yu, Hui‐Mei Xu, Ling‐Zhu Gou, Xiao‐Li Li, Gui‐Rong Yi, Yi‐Ming Lin, Ti‐Yun Han & De‐Kui Zhang. (2022) High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial . British Journal of Clinical Pharmacology 89:1, pages 232-241.
Crossref
SooIn Choi, Nayoung Kim, Ji Hyun Park, Ryoung Hee Nam, Chin‐Hee Song & Hye Seung Lee. (2022) Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis . Helicobacter 27:6.
Crossref
Young Jae Hwang, Yonghoon Choi, Nayoung Kim, Hye Seung Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2021) The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication. Digestive Diseases and Sciences 67:7, pages 3055-3066.
Crossref
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim & Miyoung Choi. (2021) Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 36:4, pages 807-838.
Crossref
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim & Miyoung Choi. (2021) Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 96:3, pages 160-189.
Crossref
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim & Miyoung Choi. (2021) Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 15:2, pages 168-195.
Crossref
Seung Joo Kang, Hye-Kyung Jung, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim & Miyoung Choi. (2021) Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 21:1, pages 35-47.
Crossref
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jeong Eun Yu, Joo Hee Son, Sun Min Lee & Dong Ho Lee. (2021) Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori . Gut and Liver 15:1, pages 53-60.
Crossref
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim & Miyoung Choi. (2020) Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 20:4, pages 261-287.
Crossref
Gitark Noh, Nayoung Kim, Yonghoon Choi, Hye Seung Lee, Young Jae Hwang, Hee Jin Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2020) Long‐term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication . Journal of Gastroenterology and Hepatology 35:9, pages 1540-1548.
Crossref
Beom Jin Kim, Hyuk Lee, Yong Chan Lee, Seong Woo Jeon, Gwang Ha Kim, Hyun-Soo Kim, Jae Kyu Sung, Dong Ho Lee, Heung Up Kim, Moo In Park, Il Ju Choi, Soon Man Yoon, Sang Wook Kim, Gwang Ho Baik, Ju Yup Lee, Jin Il Kim, Sang Gyun Kim, Jayoun Kim, Joongyup Lee, Jae Gyu Kim & Jae J. Kim. (2019) Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea . Gut and Liver 13:5, pages 531-540.
Crossref
Yong Hwan Kwon, Nayoung Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2019) Effect of Citric Acid on Accuracy of 13 C-Urea Breath Test after Helicobacter pylori Eradication Therapy in a Region with a High Prevalence of Atrophic Gastritis . Gut and Liver 13:5, pages 506-514.
Crossref
Jung W. Lee, Nayoung Kim, Ryoung H. Nam, Sun M. Lee, Yong H. Kwon, So D. Sohn, Jung M. Kim, Dong H. Lee & Hyun C. Jung. (2019) Favorable outcomes of culture‐based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance . Helicobacter 24:2, pages e12561.
Crossref
Amin Talebi Bezmin Abadi & Yoshio Yamaoka. (2018) Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 14, pages 111-117.
Crossref
Y.-J. Hwang, N. Kim, H. S. Lee, J. B. Lee, Y. J. Choi, H. Yoon, C. M. Shin, Y. S. Park & D. H. Lee. (2018) Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years . Alimentary Pharmacology & Therapeutics 47:3, pages 380-390.
Crossref
Young-Jae HwangNayoung Kim, Chang Yong YunMin Gu KwonSung Min BaekYeong Jae KwonHye Seung LeeJae Bong LeeYoon Jin ChoiHyuk YoonCheol Min ShinYoung Soo ParkDong Ho Lee. (2018) Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 18:3, pages 186.
Crossref
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam & Hang Lak Lee. (2017) Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis . Helicobacter 22:4, pages e12389.
Crossref
Yoen-Young Chuah, Deng-Chyang Wu, Seng-Kee Chuah, Jyh-Chin Yang, Tzong-Hsi Lee, Hong-Zen Yeh, Chan-Lin Chen, Yu-Hwa Liu & Ping-I Hsu. (2017) Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey) . Helicobacter 22:3, pages e12380.
Crossref
Sotirios D. Georgopoulos, Elias Xirouchakis, Beatrice Martinez-Gonzales, Evanthia Zampeli, Elias Grivas, Charikleia Spiliadi, Maria Sotiropoulou, Kalliopi Petraki, Kostantinos Zografos, Fotini Laoudi, Dionysios Sgouras, Andreas Mentis, Panagiotis Kasapidis & Spyros Michopoulos. (2016) Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. European Journal of Internal Medicine 32, pages 84-90.
Crossref
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli & Javier P Gisbert. (2016) Sequential versus standard triple first-line therapy for Helicobacter pylori eradication . Cochrane Database of Systematic Reviews 2016:6.
Crossref
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jung Mogg Kim, Jong Youn Park, Sun Min Lee, Joo Sung Kim, Dong Ho Lee & Hyun Chae Jung. (2015) High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones. Antimicrobial Agents and Chemotherapy 59:12, pages 7629-7636.
Crossref
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi & A. Di Leo. (2015) Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by ‘geographical weighting’ . International Journal of Clinical Practice 69:10, pages 1112-1120.
Crossref
Yong Hwan Kwon, Nayoung Kim, Ju Yup Lee, Yoon Jin Choi, Kichul Yoon, Jae Jin Hwang, Hyun Joo Lee, AeRa Lee, Yeon Sang Jeong, Sooyeon Oh, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2015) The Diagnostic Validity of Citric Acid-Free, High Dose 13 C-Urea Breath Test After Helicobacter pylori Eradication in Korea . Helicobacter 20:3, pages 159-168.
Crossref
Jong Yeul LeeJi Yong AhnIl Ju Choi. (2015) Historical Perspective of Helicobacter pylori Treatment in Korea . The Korean Journal of Helicobacter and Upper Gastrointestinal Research 15:4, pages 211.
Crossref
Su Young Kim. (2015) Antibiotic treatment for Helicobacter pylori : Is the end coming? . World Journal of Gastrointestinal Pharmacology and Therapeutics 6:4, pages 183.
Crossref
Wei-Chen Tai, Chih-Ming Liang, Chen-Hsiang Lee, Chien-Hua Chiu, Ming-Luen Hu, Lung-Sheng Lu, Yuan-Hung Kuo, Chung-Mou Kuo, Yi-Hao Yen, Chung-Huang Kuo, Shue-Shian Chiou, Keng-Liang Wu, Yi-Chun Chiu, Tsung-Hui Hu & Seng-Kee Chuah. (2015) Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication . BioMed Research International 2015, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.